chemXplore tracks 3 projects in Singapore, of which 2 are active.
2 new construction.
Owners and developers: Public Investment Fund (1)
Contractors and licensors are recorded on all 2 of them For subscribers
Targeting: Biogasoline (1)
Low‑fouling RO elements ordered for a 50 million gallons-per-day wastewater reclamation plant in Changi, with completion targeted in 2028.
Dual Ang‑2/VEGF‑A inhibitor delivered vision gains, lesion regression and dosing intervals up to 20 weeks for most patients in a two‑year Asian PCV trial.
Two pre-salt platforms bound for the Búzios field will sail to Brazil for 2027 start-up; each can produce 225,000 b/d and treat 12 million m³/d of gas.
Partner will lead clinical development, manufacturing and global commercialization of AID351, an anti‑dengue antibody active across four serotypes; originators retain royalty and sublicence share.
Delivered low-oxygen MEG (<20 ppb) to an offshore platform via a 20-month ship-to-ship transfer from Singapore to Dampier using nitrogen purging and five sealed handling steps.
EBITDA +7.4% YoY to €391m and margin 16.1%; organic sales +3.2%; raw-material cost spike prompted pricing moves; FY‑26 EBITDA guidance slightly above last year at constant FX.
Record quarterly EBITDA driven by USD 1,223/t renewable sales margin and strong middle‑distillate refining cracks; H2 includes three planned turnarounds and ~€1.2bn capex.
On-site methyl mercaptan production is now in Antwerp, Singapore and Mobile, completing integration and trimming DL‑methionine’s carbon footprint by ~7% while cutting hazardous intermediate transport.
Combines marketing arms and trading into an ADGM-based LNG hub, targeting 47 mtpa marketable LNG by 2035 and expanding shipping optionality.
Completes purchases of WKS Group and Wipco, signs deal for Kobewel; adds filling stations, dissolved acetylene plants, welding distribution, cylinder depots and marine services.
